Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Congrats to good job
View:
Post by Alamir1111 on May 16, 2024 7:58pm

Congrats to good job

$0.122
 
0.0 | 
0.00%
Bid:  0.00 x 0 Ask:  0.00 x 0 Volume: 0
USD  |  OTCQB  |  REALTIME  |  MARKET CLOSE$0.005
 
0.0 | 
0.00%
Bid:  0.005 x 0 Ask:  0.010 x 0 Volume: 0
 
$0.160
-0.005 | 
-3.03%
Bid: 
Comment by Alamir1111 on May 16, 2024 8:07pm
https://stockhouse.com/news/newswire/2018/06/21/theralase-cancer-therapy-in-search-medicine-s-holy-grail
Comment by Alamir1111 on May 16, 2024 8:11pm
Did he ger sued? 
Comment by Alamir1111 on May 16, 2024 8:47pm
Last couple nr.. You guys taka exlax ??
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities